Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis
Top Cited Papers
- 22 October 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (17), 2184-2187
- https://doi.org/10.1161/01.cir.0000037521.71373.44
Abstract
Background— Rheumatoid arthritis (RA) is associated with accelerated atherosclerosis and increased cardiovascular morbidity and mortality. Striking similarities exist in the inflammatory and immuno...Keywords
This publication has 13 references indexed in Scilit:
- Toll-like Receptor 4 Polymorphisms and AtherogenesisNew England Journal of Medicine, 2002
- Human TNF‐α in transgenic mice induces differential changes in redox status and glutathione‐regulating enzymesThe FASEB Journal, 2002
- Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged menEuropean Heart Journal, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Cardiovascular Mortality in Patients with Rheumatoid ArthritisCardiology, 1989
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980